Medicare Procedure and Patient Information
Conditions of Medicare patients treated by Dr. Hilary Yu-Heng Ma, MD in 2016
The most common conditions of Medicare patients that Dr. Hilary Yu-Heng Ma, MD treated during 2016 were hypertension.
75 | |
(No ratings)
Dr. Hilary Yu-Heng Ma, MD is an oncologist in Houston, TX specializing in adult oncology and adult hematology. He graduated from University of California, San Diego (UCSD), School of Medicine in 2002 and has 22 years of experience. Dr. Hilary Yu-Heng Ma, MD is affiliated with The University of Texas MD Anderson Cancer Center and PHYSICIANS REFERRAL SERVICE.
1515 Holcombe Boulevard Unit 0462
Houston, TX 77030
The most common conditions of Medicare patients that Dr. Hilary Yu-Heng Ma, MD treated during 2016 were hypertension.
Hypertension | 75 |
---|---|
High Cholesterol | 0 |
Stroke | 0 |
Ischemic Heart Disease | 0 |
Depression | 0 |
Chronic Kidney Disease | 0 |
Asthma | 0 |
Osteoperosis | 0 |
Atrial Fibrilation | 0 |
Heart Failure | 0 |
Chronic Obstructive Pulmonary Disease | 0 |
Diabetes | 0 |
Dementia | 0 |
Cancer | 0 |
The top procedures that Dr. Hilary Yu-Heng Ma, MD treated as an oncologist in Houston, TX during 2017 were and .
Volume of procedures performed by Dr. Hilary Yu-Heng Ma, MD for Medicare patients.
doctor visit | 65 |
---|
Information about Medicare patients treated by Dr. Hilary Yu-Heng Ma, MD.
Male | 25 |
---|---|
Female | 34 |
Non-Hispanic White | 0 |
---|---|
Black | 26 |
Hispanic | 16 |
Asian | 0 |
Other | 0 |
Native American | 0 |
From 65 to 74 | 0 |
---|---|
From 75 to 84 | 0 |
85 and over | 0 |
Less than 65 | 29 |
The most common conditions of Medicare patients that Dr. Hilary Yu-Heng Ma, MD treated during 2017 were hypertension, cancer, diabetes and high cholesterol.
Hypertension | 71 |
---|---|
High Cholesterol | 34 |
Stroke | 0 |
Ischemic Heart Disease | 29 |
Depression | 27 |
Chronic Kidney Disease | 27 |
Asthma | 0 |
Osteoperosis | 0 |
Atrial Fibrilation | 0 |
Heart Failure | 19 |
Chronic Obstructive Pulmonary Disease | 22 |
Diabetes | 42 |
Dementia | 0 |
Cancer | 68 |
The top procedures that Dr. Hilary Yu-Heng Ma, MD treated as an oncologist in Houston, TX during 2018 were hospital care and inpatient care.
Volume of procedures performed by Dr. Hilary Yu-Heng Ma, MD for Medicare patients.
doctor visit | 87 |
---|---|
hospital care | 15 |
inpatient care | 15 |
Information about Medicare patients treated by Dr. Hilary Yu-Heng Ma, MD.
Male | 44 |
---|---|
Female | 41 |
Non-Hispanic White | 0 |
---|---|
Black | 40 |
Hispanic | 26 |
Asian | 0 |
Other | 0 |
Native American | 0 |
From 65 to 74 | 0 |
---|---|
From 75 to 84 | 0 |
85 and over | 0 |
Less than 65 | 41 |
The most common conditions of Medicare patients that Dr. Hilary Yu-Heng Ma, MD treated during 2018 were hypertension, cancer, chronic kidney disease and high cholesterol.
Hypertension | 75 |
---|---|
High Cholesterol | 45 |
Stroke | 0 |
Ischemic Heart Disease | 32 |
Depression | 27 |
Chronic Kidney Disease | 48 |
Asthma | 0 |
Osteoperosis | 0 |
Atrial Fibrilation | 0 |
Heart Failure | 27 |
Chronic Obstructive Pulmonary Disease | 20 |
Diabetes | 42 |
Dementia | 0 |
Cancer | 74 |
The top procedures that Dr. Hilary Yu-Heng Ma, MD treated as an oncologist in Houston, TX during 2019 were and .
Volume of procedures performed by Dr. Hilary Yu-Heng Ma, MD for Medicare patients.
doctor visit | 104 |
---|
Information about Medicare patients treated by Dr. Hilary Yu-Heng Ma, MD.
Male | 47 |
---|---|
Female | 42 |
Non-Hispanic White | 0 |
---|---|
Black | 32 |
Hispanic | 35 |
Asian | 0 |
Other | 0 |
Native American | 0 |
From 65 to 74 | 34 |
---|---|
From 75 to 84 | 0 |
85 and over | 0 |
Less than 65 | 40 |
The most common conditions of Medicare patients that Dr. Hilary Yu-Heng Ma, MD treated during 2019 were hypertension, cancer, high cholesterol and diabetes.
Hypertension | 72 |
---|---|
High Cholesterol | 55 |
Stroke | 0 |
Ischemic Heart Disease | 35 |
Depression | 20 |
Chronic Kidney Disease | 43 |
Asthma | 0 |
Osteoperosis | 16 |
Atrial Fibrilation | 0 |
Heart Failure | 24 |
Chronic Obstructive Pulmonary Disease | 21 |
Diabetes | 46 |
Dementia | 0 |
Cancer | 69 |
The top procedures that Dr. Hilary Yu-Heng Ma, MD treated as an oncologist in Houston, TX during 2020 were and .
Volume of procedures performed by Dr. Hilary Yu-Heng Ma, MD for Medicare patients.
doctor visit | 30 |
---|
Information about Medicare patients treated by Dr. Hilary Yu-Heng Ma, MD.
Male | 22 |
---|---|
Female | 18 |
Non-Hispanic White | 0 |
---|---|
Black | 0 |
Hispanic | 17 |
Asian | 0 |
Other | 0 |
Native American | 0 |
From 65 to 74 | 19 |
---|---|
From 75 to 84 | 0 |
85 and over | 0 |
Less than 65 | 0 |
The most common conditions of Medicare patients that Dr. Hilary Yu-Heng Ma, MD treated during 2020 were cancer, hypertension, chronic kidney disease and high cholesterol.
Hypertension | 68 |
---|---|
High Cholesterol | 45 |
Stroke | 0 |
Ischemic Heart Disease | 0 |
Depression | 33 |
Chronic Kidney Disease | 58 |
Asthma | 0 |
Osteoperosis | 0 |
Atrial Fibrilation | 0 |
Heart Failure | 0 |
Chronic Obstructive Pulmonary Disease | 0 |
Diabetes | 43 |
Dementia | 0 |
Cancer | 73 |
The top procedures that Dr. Hilary Yu-Heng Ma, MD treated as an oncologist in Houston, TX during 2021 were and .
Volume of procedures performed by Dr. Hilary Yu-Heng Ma, MD for Medicare patients.
doctor visit | 52 |
---|
Volume of procedures performed by Dr. Hilary Yu-Heng Ma, MD for Medicare patients.
The highest averages for the top procedures that Dr. Hilary Yu-Heng Ma, MD treated as an oncologist in Houston, TX were hospital care and inpatient care.
doctor visit | 67 |
---|---|
hospital care | 15 |
inpatient care | 15 |
Information about Medicare patients treated by Dr. Hilary Yu-Heng Ma, MD.
Female | 15 |
---|---|
Male | 15 |
Black / African American | 10 |
---|---|
Asian / Pacific Islander | 0 |
Non-Hispanic White | 0 |
Hispanic | 10 |
Native American / Alaskan Native | 0 |
Other | 0 |
85 and over | 0 |
---|---|
75 to 84 | 0 |
Less than 65 | 12 |
65 to 74 | 5 |
The highest averages of the most common conditions of Medicare patients that Dr. Hilary Yu-Heng Ma, MD treated were hypertension, cancer, chronic kidney disease and diabetes.
Hypertension | 40 |
---|---|
High Cholesterol | 19 |
Stroke | 0 |
Ischemic Heart Disease | 10 |
Depression | 11 |
Chronic Kidney Disease | 19 |
Asthma | 0 |
Osteoporosis | 1 |
Heart Failure | 7 |
Chronic Obstructive Pulmonary Disease | 7 |
Diabetes | 19 |
Atrial Fibrillation | 0 |
Dementia | 0 |
Cancer | 31 |
Dr. Hilary Yu-Heng Ma, MD graduated from University of California, San Diego (UCSD), School of Medicine in 2002. He completed residency at St. Mary's Medical Center, San Francisco. He is certified by the American Board of Internal Medicine - Internal Medicine and has a state license in New York.
Medical School: University of California, San Diego (UCSD), School of Medicine (2002)
Residency: St. Mary's Medical Center, San Francisco (2005)
Board Certification: American Board of Internal Medicine - Internal Medicine
Licensed In: New York
Dr. Hilary Yu-Heng Ma, MD is associated with these hospitals and organizations:
Dr. Hilary Yu-Heng Ma, MD does not have any reviews yet, be the first to leave a review of Dr. Hilary Yu-Heng Ma, MD here: Leave a Review
(No ratings)
These charts describe general payments received by Dr. Hilary Yu-Heng Ma, MD. Doctors may receive payments for a number of reasons, including meal compensation, travel compensation, and consulting.
Pfizer Inc. |
$296
IBRANCE $274 |
TALZENNA $22 |
---|---|---|
Amgen Inc. |
$128
Neulasta $20 |
$108 |
Lilly USA, LLC |
$23
CYRAMZA $23 |
|
Celgene Corporation |
$21
Pomalyst $21 |
|
AstraZeneca Pharmaceuticals LP |
$20
CALQUENCE $20 |
|
Other |
$28
Stivarga $17 |
$12 |
Education | $403 |
---|---|
Food and Beverage | $114 |
Dr. Hilary Ma is a Houston, TX physician who specializes in adult hematology and adult oncology. Dr. Ma is affiliated with The University of Texas MD Anderson Cancer Center. He is a graduate of the University of California, San Diego (UCSD), School of Medicine. His training includes residency programs at San Francisco General Hospital and St. Mary's Medical Center, San Francisco. He has received distinctions including Faculty of the Year in Medical Oncology, NYU, NYU School of Medicine; Fellow of the Year in Hematology, NYU School of Medicine; and Community Service Scholarship, University of California, San Diego (UCSD).